Movmedix Enters U.S. Market with FDA-Cleared LARS® Technology
ARC-SUR-TILLE, France, July 6, 2026 Movmedix, the French orthopedic medical technology company behind the globally recognized LARS® synthetic ligament...
IceCure Medical
Advertisement
IceCure Expands ProSense Cryoablation in Brazil After FDA Clearance
CAESAREA, Israel, July 6, 2026 IceCure Medical Ltd. has announced accelerating commercial adoption of its ProSense™ cryoablation system in...
IceCure Reports Strong 5-Year Results in Kidney Cancer
CAESAREA, Israel, March 25, 2026 IceCure Medical has reported positive five-year top-line results from its ICESECRET clinical trial, demonstrating...
IceCure Wins Israel Approval for XSense™ Cryoablation System
CAESAREA, Israel, Sept. 15, 2025 – IceCure Medical Ltd. (NASDAQ: ICCM), a pioneer in minimally invasive cryoablation therapies, today...
Advertisement
